Quadrise Strengthens Position in Central America with Panama Trial Success – VSA Capital 24 September 2025
FirstGroup PLC (FGP.L) Stock Analysis: Navigating an 8% Upside with Strong Buy Ratings 30 September 2025
Baillie Gifford Japan Trust PL (BGFD.L): Navigating the Peaks with a 52-Week High in Sight 30 September 2025
Balfour Beatty PLC (BBY.L) Stock Analysis: Navigating Strong Revenue Growth and Solid Analyst Ratings 30 September 2025
Baillie Gifford US Growth Trust (USA.L) Stock Report: Navigating Uncharted Waters with a Market Cap of $746 Million 30 September 2025
Bankers Investment Trust Plc (BNKR.L) Stock Analysis: Riding the Upper End of Its 52-Week Range 30 September 2025
Quadrise Strengthens Position in Central America with Panama Trial Success – VSA Capital 24 September 2025
FirstGroup PLC (FGP.L) Stock Analysis: Navigating an 8% Upside with Strong Buy Ratings 30 September 2025
Baillie Gifford Japan Trust PL (BGFD.L): Navigating the Peaks with a 52-Week High in Sight 30 September 2025
Balfour Beatty PLC (BBY.L) Stock Analysis: Navigating Strong Revenue Growth and Solid Analyst Ratings 30 September 2025
Baillie Gifford US Growth Trust (USA.L) Stock Report: Navigating Uncharted Waters with a Market Cap of $746 Million 30 September 2025
Bankers Investment Trust Plc (BNKR.L) Stock Analysis: Riding the Upper End of Its 52-Week Range 30 September 2025
DENTSPLY SIRONA Inc. (XRAY) Stock Analysis: A Glimpse into Its 21.62% Potential Upside 19 August 2025
National HealthCare Corporation (NHC) Stock Analysis: A Stable Dividend Play with Robust Revenue Growth 19 August 2025
LivaNova PLC (LIVN) Stock Analysis: Healthcare Innovator’s 21% Upside Potential Captures Investor Attention 19 August 2025
Liquidia Corporation (LQDA) Stock Analysis: A Biotech Growth Story with 32% Potential Upside 19 August 2025
Kiniksa Pharmaceuticals, Ltd. (KNSA) Stock Analysis: 37.9% Potential Upside Drives Strong Investor Interest 19 August 2025
Twist Bioscience Corporation (TWST) Stock Analysis: A Healthcare Innovator with 42.76% Potential Upside 19 August 2025
Vericel Corporation (VCEL) Stock Analysis: Exploring a 48% Upside Potential with Strong Buy Ratings 19 August 2025
Guardian Pharmacy Services, Inc (GRDN) Stock Analysis: Exploring a Potential 10% Upside in the Healthcare Sector 19 August 2025
Perrigo Company plc (PRGO) Stock Analysis: Navigating a 48.72% Potential Upside with Robust Dividends 19 August 2025
Kymera Therapeutics, Inc. (KYMR) Stock Analysis: A Compelling 38.40% Potential Upside with Strong Buy Ratings 19 August 2025
Protagonist Therapeutics, Inc. (PTGX) Stock Report: Unveiling a 24% Potential Upside in the Biotech Sector 19 August 2025
Crinetics Pharmaceuticals, Inc. (CRNX) Stock Analysis: A 133% Potential Upside in the Biotech Sector 19 August 2025
CONMED Corporation (CNMD) Stock Analysis: Evaluating a 14.25% Upside Potential in the Medical Device Sector 19 August 2025
PROCEPT BioRobotics (PRCT) Stock Analysis: A Promising 62.67% Upside in the Healthcare Sector 19 August 2025
Ardent Health, Inc. (ARDT) Stock Analysis: 52.72% Potential Upside Ignites Investor Interest 19 August 2025
Alignment Healthcare, Inc. (ALHC) Stock Analysis: A 23.61% Upside Opportunity for Investors 19 August 2025
Empiric Student Property reports £1.2bn portfolio value as Unite acquisition advances 9 September 2025
Unite Group publishes Scheme Document for Empiric Acquisition and Reports Strong Lettings 9 September 2025
Quadrise Strengthens Position in Central America with Panama Trial Success – VSA Capital 24 September 2025
FirstGroup PLC (FGP.L) Stock Analysis: Navigating an 8% Upside with Strong Buy Ratings 30 September 2025
Baillie Gifford Japan Trust PL (BGFD.L): Navigating the Peaks with a 52-Week High in Sight 30 September 2025
Balfour Beatty PLC (BBY.L) Stock Analysis: Navigating Strong Revenue Growth and Solid Analyst Ratings 30 September 2025
Baillie Gifford US Growth Trust (USA.L) Stock Report: Navigating Uncharted Waters with a Market Cap of $746 Million 30 September 2025
Bankers Investment Trust Plc (BNKR.L) Stock Analysis: Riding the Upper End of Its 52-Week Range 30 September 2025
